NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/02/2026
Back to search
Official data from USPTO
NEUROPRO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEUROPRO THERAPEUTICS
ST13
US500000098791996Class
42
Filing
98791996
Registration
8279339
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/02/2026
Trademark type
Word
Nice classes
42
Filing date
10/09/2024
Registration date
06/02/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2014-01-00
First use in commerce
2014-01-00
Drawing code
4
Owner type
03
Owner location
Yachats, OR, US
Examiner
DIEFENBACH, LINDSEY OLSON
Law office
O90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NeuroPro Therapeutics, Inc.
Representatives
FRANCIS P. CISLAK BARNES & THORNBURG LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
pharmaceutical research services in the field of neurological diseases and disorders; pharmaceutical products development in the field of neurological diseases and disorders; pharmaceutical product evaluation in the field of neurological diseases and disorders
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2026
PUBO
PUBLISHED FOR OPPOSITION
04/14/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2026
EXPT
EXPARTE APPEAL TERMINATED
03/17/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2026
EXPI
EX PARTE APPEAL-INSTITUTED
02/20/2026
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/20/2026
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
02/20/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/12/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/08/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/08/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/22/2025
GNFR
FINAL REFUSAL E-MAILED
08/22/2025
CNFR
FINAL REFUSAL WRITTEN
08/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/16/2025
DOCK
ASSIGNED TO EXAMINER
06/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/18/2025
GNRT
NON-FINAL ACTION E-MAILED
04/18/2025
CNRT
NON-FINAL ACTION WRITTEN
04/18/2025
DOCK
ASSIGNED TO EXAMINER
04/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2025
NWAP
NEW APPLICATION ENTERED
10/09/2024
Continuous trademark protection
Get notified about every new filing that threatens NEUROPRO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.